COBALT advises Abbott Laboratories on sale to Mylan of non-U.S. developed markets specialty and branded generics business

Generic and specialty pharmaceuticals company Mylan acquired Abbott Laboratories’ non-U.S. developed markets specialty and branded generics business. During the transaction COBALT acted as legal advisor for Abbott Laboratories on Latvian corporate law, pharmaceuticals law and data protection issues.